Loss of claudin-1 expression correlates with malignancy of hepatocellular carcinoma

J Surg Res. 2007 May 1;139(1):68-76. doi: 10.1016/j.jss.2006.08.038. Epub 2007 Jan 30.

Abstract

Background: The prognosis for the hepatocellular carcinoma (HCC) patient is affected by invasion and metastases. The attenuated expression of adherens junction protein epithelial-cadherin (E-cad) correlates with a more malignant potential in HCC. However, the potential of the claudin (CL) family of tight junctional proteins for HCC prognosis has remained unrecognized.

Materials and methods: We immunohistochemically examined the expression of CL-1 and E-cad in resected specimens from 55 HCC cases. The percentage of CL-1- or E-cad-positive cells was counted in HCC cells and the surrounding hepatocytes and scored as 0 (0%), 1 (1-33%), 2 (34-66%), and 3 (67-100%). The expression of CL-1 or E-cad was considered "preserved" if the score in HCC was equal to or more than that in the surrounding hepatocytes, and "attenuated" if not so.

Results: In nontumorous tissue, CL-1 and E-cad were observed at the lateral surface of hepatocytes and biliary epithelial cells. In well-differentiated HCCs, the expression of CL-1 and E-cad was preserved in 12 of 14 cases. In poorly differentiated HCCs, E-cad expression was preserved in 9 of 18 cases, while CL-1 expression was preserved in only 4 cases (P<0.01 versus well-differentiated HCCs). HCCs with portal invasion showed significantly attenuated CL-1 expression than those without portal invasion (P<0.05). The survival rate after hepatectomy for HCC with attenuated CL-1 expression was significantly lower than that for HCC with preserved CL-1 expression.

Conclusions: Attenuated expression of CL-1 closely correlates with the dedifferentiation and portal invasion of HCC. Down-regulated CL-1 expression may serve as a potential marker for a poor prognosis in HCC.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cadherins / analysis
  • Carcinoma, Hepatocellular / chemistry*
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / pathology
  • Claudin-1
  • Female
  • Humans
  • Immunohistochemistry
  • Liver / chemistry
  • Liver Neoplasms / chemistry*
  • Liver Neoplasms / mortality
  • Liver Neoplasms / pathology
  • Male
  • Membrane Proteins / analysis*
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Survival Rate

Substances

  • CLDN1 protein, human
  • Cadherins
  • Claudin-1
  • Membrane Proteins